Former UFC light heavyweight champion Jon Jones wouldn’t find out his fate until next year.
In a rematch with Daniel Cormier at UFC 214, where Jones won the bout and re-captured the UFC Light Heavyweight Championship via third-round knockout. Later Jones was flagged for a potential doping violation by USADA for tested positive for banned anabolic steroid Turinabol that overturned his UFC 214 result to ‘no contest.’
Jones upcoming hearing regarding failed an in-competition drug test to his UFC 214 has been scheduled for February 2018. He was supposed to have his first hearing in front of the California State Athletic Commission (CSAC) on December 12 according to MMA fighting.
Not only that Jones was pulled from a scheduled bout against Daniel Cormier in July 2016 at UFC 200 when he tested positive for clomiphene and letrozole. Jones blamed the positive test on a sexual-performance pill refer to as “d**k pills.” he received from a teammate. Jones was suspended for a one-year as a result of a positive drug test.
He was originally stripped of his title after UFC 182 for violating the UFC’s policy with a positive test for cocaine.
With repeated drug test failure, Jones could face a suspension of up to four years when USADA rules on his case. The USADA (the UFC’s anti-doping partner) process is separate from the CSAC process.